Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
JAMA. 2011 Jun 22;305(24):2540-7. doi: 10.1001/jama.2011.862.
Patients with ST-elevation myocardial infarction (STEMI) requiring interhospital transfer for primary percutaneous coronary intervention (PCI) often have prolonged overall door-to-balloon (DTB) times from first hospital presentation to second hospital PCI. Door-in to door-out (DIDO) time, defined as the duration of time from arrival to discharge at the first or STEMI referral hospital, is a new clinical performance measure, and a DIDO time of 30 minutes or less is recommended to expedite reperfusion care.
To characterize time to reperfusion and patient outcomes associated with a DIDO time of 30 minutes or less.
DESIGN, SETTING, AND PATIENTS: Retrospective cohort of 14,821 patients with STEMI transferred to 298 STEMI receiving centers for primary PCI in the ACTION Registry-Get With the Guidelines between January 2007 and March 2010.
Factors associated with a DIDO time greater than 30 minutes, overall DTB times, and risk-adjusted in-hospital mortality.
Median DIDO time was 68 minutes (interquartile range, 43-120 minutes), and only 1627 patients (11%) had DIDO times of 30 minutes or less. Significant factors associated with a DIDO time greater than 30 minutes included older age, female sex, off-hours presentation, and non-emergency medical services transport to the first hospital. Patients with a DIDO time of 30 minutes or less were significantly more likely to have an overall DTB time of 90 minutes or less compared with patients with DIDO times greater than 30 minutes (60% [95% confidence interval {CI}, 57%-62%] vs 13% [95% CI, 12%-13%]; P < .001). Among patients with DIDO times greater than 30 minutes, only 0.6% (95% CI, 0.5%-0.8%) had an absolute contraindication to fibrinolysis. Observed in-hospital mortality was significantly higher among patients with DIDO times greater than 30 minutes vs patients with DIDO times of 30 minutes or less (5.9% [95% CI, 5.5%-6.3%] vs 2.7% [95% CI, 1.9%-3.5%]; P < .001; adjusted odds ratio for in-hospital mortality, 1.56 [95% CI, 1.15-2.12]).
A DIDO time of 30 minutes or less was observed in only a small proportion of patients transferred for primary PCI but was associated with shorter reperfusion delays and lower in-hospital mortality.
对于需要进行经皮冠状动脉介入治疗(PCI)的 ST 段抬高型心肌梗死(STEMI)患者,从首次就诊到第二次就诊医院行 PCI 的总门球时间(DTB)往往较长。门到门出(DIDO)时间,定义为从首次或 STEMI 转诊医院到达和出院的时间,是一个新的临床绩效衡量指标,建议将 DIDO 时间控制在 30 分钟或更短,以加快再灌注治疗。
描述 DIDO 时间为 30 分钟或更短时的再灌注时间和患者结局。
设计、地点和患者:这是一项回顾性队列研究,纳入了 2007 年 1 月至 2010 年 3 月期间在 ACTION 注册研究-遵循指南中,298 个 STEMI 接收中心进行的 14821 例 STEMI 患者,这些患者需要转院进行 PCI。
DIDO 时间大于 30 分钟、总 DTB 时间以及风险调整后的住院死亡率的相关因素。
DIDO 中位数为 68 分钟(四分位距 43-120 分钟),只有 1627 例(11%)患者的 DIDO 时间为 30 分钟或更短。DIDO 时间大于 30 分钟的显著相关因素包括年龄较大、女性、非工作时间就诊以及首诊医院通过非紧急医疗服务转运。与 DIDO 时间大于 30 分钟的患者相比,DIDO 时间为 30 分钟或更短的患者更有可能实现总 DTB 时间为 90 分钟或更短(60%[95%置信区间{CI},57%-62%]比 13%[95%CI,12%-13%];P<0.001)。在 DIDO 时间大于 30 分钟的患者中,只有 0.6%(95%CI,0.5%-0.8%)存在绝对溶栓禁忌证。与 DIDO 时间为 30 分钟或更短的患者相比,DIDO 时间大于 30 分钟的患者住院死亡率显著更高(5.9%[95%CI,5.5%-6.3%]比 2.7%[95%CI,1.9%-3.5%];P<0.001;住院死亡率的调整优势比,1.56[95%CI,1.15-2.12])。
尽管只有一小部分接受直接 PCI 治疗的患者的 DIDO 时间为 30 分钟或更短,但 DIDO 时间与再灌注时间更短和住院死亡率更低相关。